Life Spine, a medical device company specializing in the surgical treatment of spinal disorders, announced profit and revenue growth for 3Q18. Sales grew 47% vs. 3Q17 and the company reported an EBITA growth rate of 124% for the same period.
Chief Financial Officer Omar Faruqi noted “significant growth” across Life Spine’s micro-invasive portfolio, which includes products such as the ProLift® expandable spacer.
Life Spine, a medical device company specializing in the surgical treatment of spinal disorders, announced profit and revenue growth for 3Q18. Sales grew 47% vs. 3Q17 and the company reported an EBITA growth rate of 124% for the same period.
Life Spine, a medical device company specializing in the surgical treatment of spinal disorders, announced profit and revenue growth for 3Q18. Sales grew 47% vs. 3Q17 and the company reported an EBITA growth rate of 124% for the same period.
Chief Financial Officer Omar Faruqi noted “significant growth” across Life Spine’s micro-invasive portfolio, which includes products such as the ProLift® expandable spacer.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
